Zhejiang Taizhou Hospital
In research, Zhejiang Taizhou Hospital stands highest in Health Sciences (#2,993 of 11,982 worldwide), Medicine (#2,684 of 10,443 worldwide) and Life Sciences (#3,715 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Surgery — Oncology is 5.6× its share of world research.
- World rank, 2022–2025
- #6,423 of 28,054 · #14,283 all time
- Rank in China
- #1,341 of 3,058
- Research works
- 1.2k ▲ 24% vs 2013–17
- Citations
- 11k 8.9 per fractional work
- Top-10% rate
- 19.6% record average 16.5%
- Open access
- 44% world 28%
What is Zhejiang Taizhou Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #2,993 of 11,982 | 18.7% | 283 | #6599 | |
| MedicineField | #2,684 of 10,443 | 18.2% | 270 | #5650 | |
| Life SciencesDomain | #3,715 of 7,800 | 17.9% | 90 | #7672 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,025 of 3,579 | 18.1% | 62 | #6846 |
Each strip is that field’s whole ranked pool, with the notch where Zhejiang Taizhou Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#6,599 #2,993
- Medicine#5,650 #2,684
- Life Sciences#7,672 #3,715
- Biochemistry, Genetics and Molecular Biology#6,846 #3,025
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Zhejiang Taizhou Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 5.6× the share of its output that it takes of world research.
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.4×. Every wedge is a field page.
- Immunology and Microbiology 3.4×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Nursing 1.7×
- Neuroscience 1.2×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Dentistry 1.0×
- Health Professions 0.6×
- Psychology 0.5×
- Chemistry 0.3×
- Veterinary 0.3×
- Materials Science 0.3×
- Computer Science 0.2×
- Physics and Astronomy 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Mathematics 0.1×
- Social Sciences 0.1×
- Energy 0.1×
- Economics, Econometrics and Finance 0.1×
- Earth and Planetary Sciences 0.1×
- Decision Sciences 0.1×
- Chemical Engineering 0.1×
- Business, Management and Accounting 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Zhejiang Taizhou Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Chemotherapy, Tumor Microenvironment, Clinical Practice Guidelines, Oxidative Stress and Immunity.
- Endoscopic Resection
- GPX4
- Lipid Peroxidation
- Pathophysiology
- Surgery
- Targeted Therapy
- Neoadjuvant Therapy
- Rehabilitation
- SARS-CoV-2
- Immune Response
- Complications
- Surgical Management
- Clinical Trials
- Management
- Risk Factors
- Biomarkers
- Clinical Practice Guidelines
- Tumor Microenvironment
- Oxidative Stress
- Inflammation
- Epidemiology
- Cancer
- Chemotherapy
- Treatment
- Diagnosis
- Immunity
- Gene Expression
- Metastasis
- Immunotherapy
- Radiotherapy
- Prognostic Factors
- Cell Death
- Regulation
- Thrombosis
- Prognosis
- Biogenesis
- Adjuvant Therapy
- Critical Care
- Ferroptosis
- Hepatocellular Carcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology43▲ 2.6×96 topics
- Inflammation41▲ 4.7×69 topics
- Cancer34▲ 6.0×44 topics
- Oxidative Stress22▲ 3.2×45 topics
- Chemotherapy21▲ 7.1×23 topics
- Tumor Microenvironment20▲ 11×8 topics
- Treatment18▲ 3.5×35 topics
- Clinical Practice Guidelines15▲ 6.8×14 topics
- Diagnosis15▲ 3.8×29 topics
- Biomarkers14▲ 4.9×15 topics
- Immunity13▲ 7.6×10 topics
- Risk Factors13▲ 2.8×26 topics
- Gene Expression13▲ 5.0×12 topics
- Management13▲ 3.8×23 topics
- Metastasis12▲ 8.4×11 topics
- Clinical Trials11▲ 4.1×14 topics
- Immunotherapy11▲ 3.6×16 topics
- Surgical Management11▲ 6.3×17 topics
- Radiotherapy11▲ 6.6×12 topics
- Complications10▲ 5.0×17 topics
- Prognostic Factors10▲ 5.8×13 topics
- Immune Response10▲ 4.4×17 topics
- Cell Death10▲ 9.9×6 topics
- SARS-CoV-28▲ 6.1×6 topics
- Regulation8▲ 3.7×9 topics
- Rehabilitation8▲ 5.0×8 topics
- Thrombosis8▲ 6.6×7 topics
- Neoadjuvant Therapy8▲ 7.8×5 topics
- Prognosis7▲ 5.2×7 topics
- Targeted Therapy7▲ 7.7×5 topics
- Biogenesis7▲ 9.5×3 topics
- Surgery7▲ 4.8×9 topics
- Adjuvant Therapy7▲ 13×2 topics
- Pathophysiology7▲ 5.4×9 topics
- Critical Care7▲ 6.9×8 topics
- Lipid Peroxidation6▲ 14×2 topics
- Ferroptosis6▲ 19×1 topic
- GPX46▲ 19×1 topic
- Hepatocellular Carcinoma6▲ 7.1×3 topics
- Endoscopic Resection6▲ 14×2 topics
Which research topics does Zhejiang Taizhou Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Radiomics and Machine Learning in Medical Imaging and Cancer-related molecular mechanisms research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 4 Cancer-related molecular mechanisms research Cancer Research 4 works
- 5 RNA modifications and cancer Molecular Biology 4 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 7 Lung Cancer Research Studies Oncology 3 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 10 Shoulder Injury and Treatment Surgery 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Zhejiang Taizhou Hospital's research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Linhai
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.